[HTML][HTML] Dynamic prostate cancer transcriptome analysis delineates the trajectory to disease progression
M Bolis, D Bossi, A Vallerga, V Ceserani… - Nature …, 2021 - nature.com
Comprehensive genomic studies have delineated key driver mutations linked to disease
progression for most cancers. However, corresponding transcriptional changes remain …
progression for most cancers. However, corresponding transcriptional changes remain …
Dynamic prostate cancer transcriptome analysis delineates the trajectory to disease progression
M Bolis, D Bossi, A Vallerga, V Ceserani… - Nature …, 2021 - elibrary.ru
The results shown here are in whole or part based upon data generated by the TCGA
Research Network: https://www. cancer. gov/tcga. J.-PPT is funded by Swiss National …
Research Network: https://www. cancer. gov/tcga. J.-PPT is funded by Swiss National …
Dynamic prostate cancer transcriptome analysis delineates the trajectory to disease progression.
M Bolis, D Bossi, A Vallerga, V Ceserani… - Nature …, 2021 - search.ebscohost.com
Comprehensive genomic studies have delineated key driver mutations linked to disease
progression for most cancers. However, corresponding transcriptional changes remain …
progression for most cancers. However, corresponding transcriptional changes remain …
Dynamic prostate cancer transcriptome analysis delineates the trajectory to disease progression.
M Bolis, D Bossi, A Vallerga, V Ceserani, M Cavalli… - 2021 - researchsquare.com
Comprehensive genomic studies have delineated key driver mutations linked to disease
progression for most cancers. However, corresponding transcriptional changes remain …
progression for most cancers. However, corresponding transcriptional changes remain …
Dynamic prostate cancer transcriptome analysis delineates the trajectory to disease progression.
M Bolis, D Bossi, A Vallerga, V Ceserani… - Nature …, 2021 - boris.unibe.ch
Comprehensive genomic studies have delineated key driver mutations linked to disease
progression for most cancers. However, corresponding transcriptional changes remain …
progression for most cancers. However, corresponding transcriptional changes remain …
Dynamic prostate cancer transcriptome analysis delineates the trajectory to disease progression
M Bolis, D Bossi, A Vallerga, V Ceserani… - Nature …, 2021 - ui.adsabs.harvard.edu
Comprehensive genomic studies have delineated key driver mutations linked to disease
progression for most cancers. However, corresponding transcriptional changes remain …
progression for most cancers. However, corresponding transcriptional changes remain …
Dynamic prostate cancer transcriptome analysis delineates the trajectory to disease progression.
M Bolis, D Bossi, A Vallerga, V Ceserani… - Nature …, 2021 - europepmc.org
Comprehensive genomic studies have delineated key driver mutations linked to disease
progression for most cancers. However, corresponding transcriptional changes remain …
progression for most cancers. However, corresponding transcriptional changes remain …
[PDF][PDF] Dynamic prostate cancer transcriptome analysis delineates the trajectory to disease progression
M Bolis, D Bossi, A Vallerga, V Ceserani, M Cavalli - 2021 - scholar.archive.org
Comprehensive genomic studies have delineated key driver mutations linked to disease
progression for most cancers. However, corresponding transcriptional changes remain …
progression for most cancers. However, corresponding transcriptional changes remain …
Dynamic prostate cancer transcriptome analysis delineates the trajectory to disease progression
M Bolis, D Bossi, A Vallerga, V Ceserani… - Nature …, 2021 - zora.uzh.ch
Comprehensive genomic studies have delineated key driver mutations linked to disease
progression for most cancers. However, corresponding transcriptional changes remain …
progression for most cancers. However, corresponding transcriptional changes remain …
Dynamic prostate cancer transcriptome analysis delineates the trajectory to disease progression
M Bolis, D Bossi, A Vallerga… - Nature …, 2021 - pubmed.ncbi.nlm.nih.gov
Comprehensive genomic studies have delineated key driver mutations linked to disease
progression for most cancers. However, corresponding transcriptional changes remain …
progression for most cancers. However, corresponding transcriptional changes remain …